GeoVax Labs, Inc.
GOVX
$1.28
-$0.06-4.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -40.63% | 6.65% | |||
| Gross Profit | 40.63% | -30.10% | |||
| SG&A Expenses | 8.84% | -13.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -30.31% | 1.63% | |||
| Operating Income | 30.31% | -17.61% | |||
| Income Before Tax | 30.08% | -17.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.08% | -17.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.08% | -17.67% | |||
| EBIT | 30.31% | -17.61% | |||
| EBITDA | 30.41% | -17.67% | |||
| EPS Basic | 67.28% | 10.91% | |||
| Normalized Basic EPS | 67.28% | 10.91% | |||
| EPS Diluted | 67.28% | 10.91% | |||
| Normalized Diluted EPS | 67.28% | 10.91% | |||
| Average Basic Shares Outstanding | 113.73% | 32.08% | |||
| Average Diluted Shares Outstanding | 113.73% | 32.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||